Sygnis’ acquisition of C.B.S. Scientific


Heuking Kühn Lüer Wojtek advised Sygnis AG on the acquisition of C.B.S. Scientific Company Inc. in San Diego

Sygnis hopes to achieve sales synergies and a large potential for sales growth. It expects to realize cost savings by merging C.B.S. Scientific with the San Diego facilities of Expedeon.

C.B.S. Scientific Company Inc. is a provider of life science instruments. The company is headquartered in San Diego, USA. Estimated 2016 sales exceed $1.5 million.

Sygnis AG, based in Germany, specializes in the development and marketing of innovative products for the life science sector with special focus in the genetic and proteomic environments, DNA amplification and sequencing. The company is listed on the German Stock Exchange in the Prime Standard segment.

Heuking Kühn Lüer Wojtek has advised Sygnis AG with Thorsten Kuthe (Picture) (Lead), Meike Dresler-Lenz and Christopher Görtz (all Corporate/M&A), Cologne

Involved fees earner: Thorsten Kuthe – Heuking Kühn Lüer Wojtek; Meike Dresler-Lenz – Heuking Kühn Lüer Wojtek; Christopher Görtz – Heuking Kühn Lüer Wojtek;

Law Firms: Heuking Kühn Lüer Wojtek;

Clients: Sygnis AG;

Print Friendly, PDF & Email